292 related articles for article (PubMed ID: 30386532)
1. New insights on atherosclerosis: A cross-talk between endocannabinoid systems with gut microbiota.
Moludi J; Alizadeh M; Lotfi Yagin N; Pasdar Y; Nachvak SM; Abdollahzad H; Sadeghpour Tabaei A
J Cardiovasc Thorac Res; 2018; 10(3):129-137. PubMed ID: 30386532
[TBL] [Abstract][Full Text] [Related]
2. [Gut microbiota and its metabolite trimethylamine-N-oxide (TMAO): a novel regulator in coronary artery disease].
Li Y; Cui M; Sun J; Wei Q; Liu M; Zhang J; Qi H; Zhao L; Fang H; Chen Z; Lü S
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3745-3756. PubMed ID: 34841781
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of TMAO through probiotics and its potential role in atherosclerosis.
Din AU; Hassan A; Zhu Y; Yin T; Gregersen H; Wang G
Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9217-9228. PubMed ID: 31655880
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease.
El Hage R; Al-Arawe N; Hinterseher I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768722
[TBL] [Abstract][Full Text] [Related]
6. Novel insights in the relationship of gut microbiota and coronary artery diseases.
Ramírez-Macías I; Orenes-Piñero E; Camelo-Castillo A; Rivera-Caravaca JM; López-García C; Marín F
Crit Rev Food Sci Nutr; 2022; 62(14):3738-3750. PubMed ID: 33399007
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3.
Luo T; Guo Z; Liu D; Guo Z; Wu Q; Li Q; Lin R; Chen P; Ou C; Chen M
Gut Microbes; 2022; 14(1):2077602. PubMed ID: 35613310
[TBL] [Abstract][Full Text] [Related]
8. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis.
Liu Y; Dai M
Mediators Inflamm; 2020; 2020():4634172. PubMed ID: 32148438
[TBL] [Abstract][Full Text] [Related]
9.
Wang Q; Guo M; Liu Y; Xu M; Shi L; Li X; Zhao J; Zhang H; Wang G; Chen W
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334879
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.
Zhu Y; Li Q; Jiang H
APMIS; 2020 May; 128(5):353-366. PubMed ID: 32108960
[TBL] [Abstract][Full Text] [Related]
11. A Multi-omic Association Study of Trimethylamine N-Oxide.
Manor O; Zubair N; Conomos MP; Xu X; Rohwer JE; Krafft CE; Lovejoy JC; Magis AT
Cell Rep; 2018 Jul; 24(4):935-946. PubMed ID: 30044989
[TBL] [Abstract][Full Text] [Related]
12. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
Front Immunol; 2020; 11():574500. PubMed ID: 33042155
[TBL] [Abstract][Full Text] [Related]
14. Gut-Flora-Dependent Metabolite Trimethylamine-N-Oxide Promotes Atherosclerosis-Associated Inflammation Responses by Indirect ROS Stimulation and Signaling Involving AMPK and SIRT1.
Zhou S; Xue J; Shan J; Hong Y; Zhu W; Nie Z; Zhang Y; Ji N; Luo X; Zhang T; Ma W
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014845
[TBL] [Abstract][Full Text] [Related]
15. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack.
Yin J; Liao SX; He Y; Wang S; Xia GH; Liu FT; Zhu JJ; You C; Chen Q; Zhou L; Pan SY; Zhou HW
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26597155
[TBL] [Abstract][Full Text] [Related]
16. Trimethylamine N-Oxide Generated by the Gut Microbiota: Potential Atherosclerosis Treatment Strategies.
Zhu B; Ren H; Xie F; An Y; Wang Y; Tan Y
Curr Pharm Des; 2022; 28(35):2914-2919. PubMed ID: 36121073
[TBL] [Abstract][Full Text] [Related]
17. Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice.
Liu C; Li Z; Song Z; Fan X; Shao H; Schönke M; Boon MR; Rensen PCN; Wang Y
Atherosclerosis; 2022 Dec; 362():47-55. PubMed ID: 36347649
[TBL] [Abstract][Full Text] [Related]
18. A red wine intervention does not modify plasma trimethylamine N-oxide but is associated with broad shifts in the plasma metabolome and gut microbiota composition.
Haas EA; Saad MJA; Santos A; Vitulo N; Lemos WJF; Martins AMA; Picossi CRC; Favarato D; Gaspar RS; Magro DO; Libby P; Laurindo FRM; Da Luz PL;
Am J Clin Nutr; 2022 Dec; 116(6):1515-1529. PubMed ID: 36205549
[TBL] [Abstract][Full Text] [Related]
19. Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota.
Ma SR; Tong Q; Lin Y; Pan LB; Fu J; Peng R; Zhang XF; Zhao ZX; Li Y; Yu JB; Cong L; Han P; Zhang ZW; Yu H; Wang Y; Jiang JD
Signal Transduct Target Ther; 2022 Jul; 7(1):207. PubMed ID: 35794102
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Immunity and Gut Microbiota in Atherogenesis.
Yamashita T
J Atheroscler Thromb; 2017 Feb; 24(2):110-119. PubMed ID: 27928097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
